Value Sense
WST
West Pharmaceutical Services, Inc. (WST)
Last Price$228.1(1.8%)
Market Cap$16.9B
Intrinsic value score
6/10
Good
Intrinsic value
$152.8
DCF value - $102.8 Relative value - $202.9
Overvalued
33.0%
LTM P/E
34.3x
Peer set median 26.9x
Discount rate
8.6%
WST
is 33.0% overvalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

WST Intrinsic value

Key Highlights:
Relative Value vs Current Share Price
As of Mar 03, 2025 WST Relative Value is $206.4, which is overvalued by 9.5%, compared to current share price of $228.1.
DCF Value vs Current Share Price
As of Mar 03, 2025 WST DCF Value is $103.0, which is overvalued by 54.8%, compared to current share price of $228.1.
Methodology
Price per share, $
WST
Intrinsic value$152.8
Overvalued by33.0%
Current share price
228.1
Relative value
206.4
DCF value
103.0

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Low P/E stocks

Low P/E stocks

Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.

3M Return 7.5%
S&P Outperformance -5.5%
Next 3M Predicted Return 10.2%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%

WST Historical Intrinsic Value

Crunching data... Almost there!

WST vs Peer Set: Intrinsic Value Comparison

General

Intrinsic Value

Financials

Company name

Undervaluation/Overvaluation

Revenue growth

EPS growth

Net income margin

West Pharmaceutical Services, Inc. logo
West Pharmaceutical Services, Inc.WST
(33.0%)
(1.9%)
(15.5%)
17.0%
Median Peer Set
3.4%
23.0%
10.2%
Intuitive Surgical, Inc. logo
Intuitive Surgical, Inc.ISRG
(81.3%)
17.2%
27.7%
27.8%
Repligen Corporation logo
Repligen CorporationRGEN
(80.8%)
(21.1%)
(80.9%)
5.6%
Masimo Corporation logo
Masimo CorporationMASI
(26.6%)
0.6%
(42.5%)
4.0%
ResMed Inc. logo
ResMed Inc.RMD
(18.2%)
10.9%
13.4%
21.8%
Alcon Inc. logo
Alcon Inc.ALC
(13.6%)
8.5%
182.9%
10.3%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
1.2%
8.4%
32.2%
10.1%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
15.0%
4.2%
18.3%
8.4%
AptarGroup, Inc. logo
AptarGroup, Inc.ATR
19.0%
2.7%
30.2%
10.5%
Baxter International Inc. logo
Baxter International Inc.BAX
51.1%
(69.5%)
(100.0%)
(6.9%)
Hologic, Inc. logo
Hologic, Inc.HOLX
108.2%
(0.0%)
81.1%
19.6%

Explore more intrinsic value tools hub for WST

Peter Lynch Fair Value
Intrinsic Value
Earnings Power Value
Ben Graham Fair Value
Earnings growth model
DCF value calculator
Discount rate
Peter Lynch charts
Reverse DCF
Relative Value

FAQ

What is West Pharmaceutical Services, Inc. intrinsic value?

As of Mar 03, 2025, West Pharmaceutical Services, Inc. Intrinsic Value is $152.8. This suggests it may be overvalued by 33.0% compared to its current price of around $228.1.

What is West Pharmaceutical Services, Inc. DCF (discounted cash flow) valuation?

As of Mar 03, 2025, West Pharmaceutical Services, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at $103.0. This suggests it may be overvalued by 54.8% to its current price of around $228.1, using a discount rate of 8.6% and terminal growth rate of 3.0%.

Is West Pharmaceutical Services, Inc. overvalued or undervalued?

West Pharmaceutical Services, Inc. is currently considered overvalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $152.8, compared to a market price of around $228.1. This suggests a potential overvaluation of 33.0%.